According to a document from the German health ministry, the German government is “ready to start talks” with the new US administration to agree on changes in US policy that prioritize the local supply of coronavirus vaccine to facilities US production.
In a lengthy paper released Tuesday that answered questions from German Social Democrats, the health ministry explains why the United States managed to secure an additional supply of BioNTech / Pfizer vaccines for specific dates, while increasing supply. of the EU is scheduled for 2021. ”
The Ministry of Health states that an executive order from the president of the United States meant that “it is recommended that the country’s production facilities initially put the vaccine in supply in the United States.” This meant that the European production sites for the BioNTech / Pfizer vaccine, as well as the Modern vaccine, needed to supply the rest of the world, in addition to Europe.
“Companies, as well as the federal government, want to enter into talks with the new U.S. administration to get adjustments,” the health ministry wrote.
The document also discussed Germany’s bilateral agreement with BioNTech / Pfizer, which the Commission has left Germany out of the network, although it appears to go against the bloc’s effort to develop a joint vaccination strategy. .
In question, explained the Ministry of Health, is the funding received by BioNTech from the German Ministry of Education and Research. With this cash, BioNTech had to provide a portion of the vaccines in Germany. As a result, the health ministry had to issue a letter of pre-contractual intentions in the form of a memorandum of understanding on Sept. 8 for an additional 30 million doses of the vaccine, the health ministry wrote.